Hippel James 4

Accession 0001062993-24-018333

CIK 0000842023other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:46 PM ET

Size

28.9 KB

Accession

0001062993-24-018333

Form 4

Period: 2024-11-01

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2024-11-01$75.31/sh−6,475$487,632→ 106,610 total
Award
Restricted Stock Units
2024-11-01+34,634→ 34,634 total
→ Common Stock (34,634 underlying)
Exercise/Conversion
Common Stock
2024-11-01+13,159→ 113,085 total
Exercise/Conversion
Restricted Stock Units
2024-11-01−13,159→ 13,159 total
→ Common Stock (13,159 underlying)

Holdings

Stock Options (Right to Buy)
Exercise: $31.26Exp: 2024-08-09→ Common Stock (53,867 underlying)
53,867
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (45,220 underlying)
45,220
Performance Restricted Stock Units
→ Common Stock (13,865 underlying)
13,865
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (45,923 underlying)
45,923
Restricted Stock Units
→ Common Stock (12,031 underlying)
12,031
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (186,068 underlying)
186,068
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (32,417 underlying)
32,417
Stock Options (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (40,536 underlying)
40,536
Stock Options (Right to Buy)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (168,620 underlying)
168,620
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (37,314 underlying)
37,314
Performance Restricted Stock Units
→ Common Stock (24,062 underlying)
24,062
Performance Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (33,916 underlying)
33,916
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (167,328 underlying)
167,328
Performance Restricted Stock Units
→ Common Stock (10,912 underlying)
10,912

Footnotes (12)

[F1]Fully exercisable.
[F10]4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
[F11]Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
[F12]11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
[F2]Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
[F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
[F4]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F5]Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
[F6]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F7]Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
[F8]On 11/1/2024, the Board of Directors certified vesting of ____ performance RSUs. The remaining 13,159 restricted stock units vest on 11/1/2025.
[F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother